Intermediate for Tedizolid. Tedizolid (formerly torezolid, trade name Sivextro) is an oxazolidinone-class antibiotic for the treatment of acute bacterial skin and skin structure infections (also known as complicated skin and skin-structure infections (cSSSIs)). Tedizolid has been approved by the U.S Food and Drug Administration on June 20, 2014.
Product Name: 5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine
CAS Number: 380380-64-3
Molecular Weight:  240.0619
Molecular Formula:  C7H6BrN5
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.